RHEOMETRIC SCIENTIFIC INC
NT 10-Q, 1995-05-11
MEASURING & CONTROLLING DEVICES, NEC
Previous: BERRY PETROLEUM CO, 10-Q, 1995-05-11
Next: NATIONWIDE HEALTH PROPERTIES INC, 10-Q, 1995-05-11



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
FORM 12b-25
Commission File Number   0-14617
NOTIFICATION OF LATE FILING
                                
(Check One):[ ]Form 10-K [ ]Form 11-K [ ]Form 20-F
[X]Form 10-Q [ ]Form N-SAR

For Period Ended: March 31, 1995

[  ] Transition Report on Form 10-K  [  ] Transition
Report on Form 10Q [  ] Transition Report on
Form 20-F  [  ] Transition Report on Form N-SAR
[  ] Transition Report on Form 11-K

For the Transition Period Ended:

     Nothing in this form shall be construed to imply that
the Commission has verified any information contained
herein.

     If the notification relates to a portion of the
filing checked above, identify the Item(s) to which the
notification relates:  N/A

Part I.  Registrant Information
                                
Full name of registrant:  Rheometric Scientific, Inc.

Former name if applicable:  Rheometrics, Inc.

Address of principal executive office (Street and number):
One Possumtown Road
City, State and Zip Code:  Piscataway, New Jersey   08854
Part II. Rule 12b-25 (b) and (c)

     If the subject report could not be filed without
unreasonable efforts or expense and the registrant seeks
relief pursuant to Rule 12b-25(b), the following should be
completed.  (Check appropriate box.)

[X]  (a)  The reasons described in reasonable detail in
  Part III of this form could not be eliminated without
  unreasonable effort or expense;

[X]  (b)  The subject annual report, semi-annual report,
  transition report of Form 10-K, 20-F, 11-K or Form N-
  SAR, or portion thereof will be filed on or before the
  15th calendar day following the prescribed due date; or
  the subject quarterly report or transition report on
  From 10-Q, or portion thereof will be filed on or before
  the fifth calendar day following the prescribed due
  date; and

[ ]  (c)  The accountant's statement or other exhibit
  required by Rule 12b-25(c) has been attached if
  applicable.

                      Part III.  Narrative

     State below in reasonable detail the reasons why Form
10-K, 11-K, 10-Q, N-SAR or the transition report portion
thereof could not be filed within the prescribed time
period.  (Attach extra sheets if needed.)

The Form 10-Q could not be filed within the prescribed
time period because the Company was in the process of
obtaining certain information to be disclosed within the
financial statements, and management's discussion
analysis.
                                
Part IV.  Other Information

     (1) Name and telephone number of person to contact in
regard to this notification

Name: John C. Fuhrmeister, V.P., Finance & Admin.
Telephone: (908) 560-8550

     (2)  Have all other periodic reports required under
Section 13 or 15(d) of the Securities Exchange Act of 1934
or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that
the registrant was required to file such report(s) been
filed?  If the answer is no, identify report(s):  [X] Yes
[ ] No

     (3)  Is it anticipated that any significant change in
results of operations from the corresponding period for
the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion
thereof?: [ ] Yes  [X] No

     If so:  attach an explanation of the anticipated
change, both narratively and quantiatively, and, if
appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
                                
Name of registrant as specified in charter: Rheometric
Scientific, Inc.
                                
Has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.

Date:  May 11, 1995

By: /s/ J C Fuhrmeister
John C. Fuhrmeister, Assistant Secretary and
Vice President, Finance and Administration

     Instruction.  The form may be signed by an executive
officer of the registrant or by any other duly authorized
representative.  The name and title of the person signing
the form shall be typed or printed beneath the signature.
If the statement is signed on behalf of the registrant by
an authorized representative (other than an executive
officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the
form.

ATTENTION

     International misstatements or omissions of a fact
constitute Federal criminal violations (see 18 U.S.C.
1001).

GENERAL INSTRUCTIONS

     1.  This form is required by Rule 12b-25 of the
General Rules and Regulations under the Securities
Exchange Act of 1934.

     2.  One signed original and four conformed copies of
this form and amendments thereto must be completed and
filed with the Securities and Exchange Commission,
Washington, D.C. 20549, in accordance with Rule 0-3 of the
General Rules and Regulations under the Act.  The
information contained in or filed with the form will be
made a matter of the public record in the Commission
files.

     3.  A manually signed copy of the form and amendments
thereto shall be filed with each national securities
exchange on which any class of securities of the
registrant is registered.

     4.  Amendments to the notifications must also be
filed on Form 12b-25 but need not restate information that
has been correctly furnished.  The form shall be clearly
identified as an amended notification.

     5.  Electronic Filers.  This form shall not be used
by electronic filers unable to timely file a report solely
due to electronic difficulties.  Filers unable to submit a
report within the time period prescribed due to
difficulties in electronic filing should comply with
either Rule 201 or Rule 202 of Regulation S-T or apply for
an adjustment in filing date pursuant to Rule 13(b) of
Regulation S-T.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission